People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Biotechnology, Biotech, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Orgenesis Inc. | — | Biotechnology | Series A | $35.2M | $14.4M | 2013 |
| Orpheus Bioscience, Inc. | — | Biotech | Seed | $4.4M | $140.2M | 2017 |
| Retrieve Medical Holdings, Inc. | — | Healthtech | Seed | $2.3M | $8.1M | 2014 |
| Exxel Pharma, INC. | — | Biotechnology | Pre-Seed | $600K | $2.2M | 2024 |
Guy Yachin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Guy Yachin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Soren Mogelsvang | 2 | 2 |
| Cohava Gelber | 2 | 2 |
| Vered Caplan | 2 | 2 |
| David Sidransky | 1 | 7 |
| John Abeles | 1 | 4 |
| Victor Miller | 1 | 4 |
| JERRY SWON | 1 | 3 |
| Joerg Klaube | 1 | 3 |
| Mark Rosenberg | 1 | 3 |
| Elliot Maltz | 1 | 2 |
| Arnold Tinter | 1 | 2 |
| Yaron Adler | 1 | 2 |
| Ashish Nanda | 1 | 1 |
| Darren Head | 1 | 1 |
| Dennis Bedoret | 1 | 1 |
| Hugues Bultot | 1 | 1 |
| Etti Hanochi | 1 | 1 |
| Yachin Yachin | 1 | 1 |
| Neil Reithinger | 1 | 1 |
| Ferber Ferber | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.